与Miller-Fisher综合征相关的Takotsubo心肌病
51岁女性,表现为进行性感觉异常、下肢麻木、复视和行走困难,查体示反射消失和上睑下垂。初始心电图非特异性ST段改变,肌钙蛋白T升高至0.41ng/mL,峰值0.66ng/mL。超声心动图示左室射血分数降至35%,前壁和左室心尖部严重运动减弱。肌电图神经传导研究示所有神经传导速度严重减慢和远端潜伏期延长,符合脱髓鞘疾病。接受5天静脉注射免疫球蛋白治疗,下肢肌力显著改善;4天后复查超声心动图示左室射血分数改善至55%,无左室壁运动异常。文献回顾未发现Miller-Fisher综合征相关Takotsubo心肌病的病例。
要点
- Miller-Fisher综合征急性期可并发Takotsubo心肌病,表现为左室射血分数降低(本例35%)和左室壁运动异常。
- Takotsubo心肌病需与Miller-Fisher综合征的自主神经功能障碍鉴别,两者治疗方案不同。
- 本例接受5天静脉注射免疫球蛋白治疗后下肢肌力显著改善,4天后左室射血分数恢复至55%。
- Takotsubo心肌病的治疗为支持性,推荐使用β受体阻滞剂和血管紧张素转换酶抑制剂直至左室射血分数改善。
- 文献回顾未发现Miller-Fisher综合征相关Takotsubo心肌病的既往病例报告。
适用人群与场景
- 表现为进行性感觉异常、下肢麻木、复视和行走困难的Miller-Fisher综合征患者。
处置流程与药物剂量
- 本例接受5天静脉注射免疫球蛋白治疗。
- Takotsubo心肌病的治疗为支持性,推荐使用β受体阻滞剂和血管紧张素转换酶抑制剂直至左室射血分数改善。
红旗征与不能漏的情况
- Miller-Fisher综合征因显著自主神经功能障碍可能导致心律失常、血压变化、急性冠脉综合征和心肌炎,Takotsubo心肌病难以与之区分。
研究设计与关键结果
- 51岁女性Miller-Fisher综合征患者,初始心电图非特异性ST段改变,肌钙蛋白T升高至0.41ng/mL,峰值0.66ng/mL。
- 超声心动图示左室射血分数降至35%,前壁和左室心尖部严重运动减弱。
- 肌电图神经传导研究示所有神经传导速度严重减慢和远端潜伏期延长,符合脱髓鞘疾病。
- 接受5天静脉注射免疫球蛋白治疗后下肢肌力显著改善。
- 4天后复查超声心动图示左室射血分数改善至55%,无左室壁运动异常。
证据类型、等级与局限
- 病例报告。
- 局限:原文未报告局限性。
对床旁实践的改变
- Miller-Fisher综合征急性期需警惕Takotsubo心肌病,应与自主神经功能障碍鉴别,两者治疗方案不同。
- 作者认为Takotsubo心肌病的治疗为支持性,推荐使用β受体阻滞剂和血管紧张素转换酶抑制剂直至左室射血分数改善。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
51-year-old female who presented with progressive paresthesia, numbness of the lower extremities, double vision, and trouble walking. Physical exam was remarkable for areflexia, and ptosis. Her initial EKG showed nonspecific ST segment changes and her Troponin T was elevated to 0.41ng/mL which peaked at 0.66ng/mL. Echocardiogram showed a depressed left ventricular ejection fraction to 35% with severely hypokinetic anterior wall and left ventricular apex was severely hypokinetic. EMG nerve conduction study showed severely decreased conduction velocity and prolonged distal latency in all nerves consistent with demyelinating disease. She was treated with 5days of intravenous immunoglobulin therapy to which she showed significant improvement in strength in her lower extremities. Echocardiogram repeated 4days later showing an improved left ventricular ejection fraction of 55% and no left ventricular wall motion abnormalities. Takotsubo cardiomyopathy is a rare complication of Miller-Fisher syndrome and literature review did not reveal any cases. Miller-Fisher syndrome is an autoimmune process that affects the peripheral nervous system causing autonomic dysfunction which may involve the heart. Due to significant autonomic dysfunction in Miller-Fisher syndrome, it could lead to arrhythmias, blood pressure changes, acute coronary syndrome and myocarditis, Takotsubo cardiomyopathy can be difficult to distinguish. The treatment of Takotsubo cardiomyopathy is supportive with beta-blockers and angiotensin-converting enzyme inhibitors are recommended until left ventricle ejection fraction improvement. Takotsubo cardiomyopathy is a rare complication during the acute phase of Miller-Fisher syndrome and must be distinguished from autonomic dysfunction as both diagnoses have different approaches to treatment.
参考来源
- Gill D, Liu K. Takotsubo cardiomyopathy associated with Miller-Fisher syndrome. Am J Emerg Med. 2016. PMID: 28040387. doi:10.1016/j.ajem.2016.12.050
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。